Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 9, 2013

View Archived Issues

Development of a targeted immunotoxin for the destruction of brain cancer cells in glioblastomas

First phase II results of a transdermal BA-058 microneedle patch for the treatment of osteoporosis

PTC Therapeutics identifies novel fused 2-pyridones active against resistant bacteria

Discovery of novel cathepsin K inhibitors for bone resorption

Viriom reports data from international trial of HIV drug candidate

Continued clinical benefit of tildrakizumab for 1 year in chronic psoriasis

2B3-201 as a strategy for sustained and nontoxic release of methylprednisolone

Bharat Biotech launches inactivated Japanese encephalitis vaccine

Boost to MAX BioPharma's oxysterol program through licensing and SBIR grant

Almac Discovery patent describes novel protein kinase Akt inhibitors

Bristol-Myers Squibb prepares and tests HIV attachment inhibitors

Liver X receptor-beta agonists reported in Vitae Pharmaceuticals patent

Minerva Patents presents compound for ischemic reperfusion injury

Bayer selects drug candidates for accelerated development and expands indications for approved drugs

FDA accepts filing of Zerenex NDA

Janssen acquires NS5A inhibitor from GlaxoSmithKline for hepatitis C

University of Queensland and Leo Pharma form strategic skin cancer collaboration

Edimer begins phase II trial in XLHED-affected male newborns

Pfizer in-licenses preclinical program on early-onset morbid obesity

GSK reports results from large-scale phase III trial of malaria vaccine RTS,S

Active Biotech receives milestone payment for tasquinimod trial

FDA approves Adempas for CTEPH and PAH

Hutchison MediPharma and Eli Lilly sign agreement for fruquintinib

Forma Therapeutics meets first objective in collaboration with Celgene

ILC receives orphan drug designation in Europe for osteosarcoma

VAC-3S vaccine: first-in-human safety, dose and immunization results

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...